Canada Varicose Vein Treatment Devices Market Report: Market Size & Forecast 2026

The North American varicose vein treatment devices market encompasses a range of technologies designed to address chronic venous insufficiency, including endovenous laser and radiofrequency ablation systems, sclerotherapy agents, and compression therapy devices. With a 2025 regional valuation of approximately USD 1.45 billion and a projected CAGR of 6.78%, the market reflects sustained demand driven by a large patient population and increasing adoption of minimally invasive procedures.

• •North America commands the largest regional share globally, exceeding 44% of worldwide revenue according to industry trackers
• •The United States alone accounts for an estimated USD 532.12 million of the regional market in 2025
• •Canada's domestic varicose vein treatment devices market is projected to reach approximately USD 77 million by 2028

An aging population stands as the primary catalyst for market expansion, as venous disease prevalence increases significantly with age. Concurrently, rising obesity rates across North America contribute to higher incidence of varicose veins and chronic venous disorders.

• •Statistics Canada census data confirms a growing elderly demographic, though it does not specifically track venous disease prevalence
• •Public health data from Canada.ca (Census 2021) documents the aging trend underpinning venous treatment demand across the country
• •Obesity is a well-established risk factor for venous insufficiency, and elevated rates across both Canada and the United States drive patient volume

Within North America, the United States constitutes the dominant market due to its larger population, higher healthcare spending, and broader reimbursement coverage for venous procedures. Canada's smaller market is growing at a comparable rate of 6.6% CAGR, supported by its aging population and gradual adoption of advanced ablation technologies.

• •North America holds over 44% of the global varicose vein treatment devices market, making it the single largest regional segment worldwide
• •The US market is expected to grow at a 5.84% CAGR through 2031 from its 2025 baseline
• •Canada's market is on track to reach approximately USD 77 million by 2028, reflecting near-parallel growth dynamics to the broader North American region

What are the recent trends and outlook?

Minimally invasive procedures such as endovenous laser ablation and radiofrequency ablation continue to displace traditional surgical stripping due to improved patient outcomes and shorter recovery times. Market projections through 2030 consistently point to steady growth, with North America maintaining its leadership position as emerging technologies and favorable demographic trends sustain demand.

• •The global market is projected to reach between USD 1.715 billion and USD 2.14 billion by 2030 depending on the research estimate, representing continued expansion from 2025 levels
• •Advancements in foam sclerotherapy formulations and closure devices are broadening the range of treatable venous conditions
• •Industry-tracked data consistently indicates North America will retain its dominant regional share through the end of the current decade